Thursday, November 09, 2017 10:15 PM ET
Insider Makes Significant Stock buy in Dexcom (DXCM) Shares Breaks Selling Trend of Last 90 Days
There was a noteworthy insider buy in Dexcom shares today as revealed in a filing with the SEC. One insider — Steven R Altman, Director — acquired 25,000 shares in the company having a net market value of approximately $1,250,250. There have been 5 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the purchase of 10,000 company shares and the disposition of 25,586 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 9,414 shares and have averaged 10,098 shares per transaction over this time period.
The number of insider buy/sell trades at Dexcom is greater than that of the 82 peer company average over the last 90-day period. The Medical Equipment, Supplies & Distribution peer group saw 92 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Dexcom insiders is lower than its peers. Within the peer group there were 657,380 shares purchased and 1,206,589 shares sold with company insiders selling 5,970 shares on average over this time period.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data used to evaluate and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.